Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
Schmid
C
C
Schleuning
M
M
Aschan
J
J
Ringdén
O
O
Hahn
J
J
Holler
E
E
Hegenbart
U
U
Niederwieser
D
D
Dugas
M
M
Ledderose
G
G
Kolb
H-J
HJ
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality; D006801:Humans; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016019:Survival Analysis; D014184:Transplantation, Homologous
D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor